China channel feed

BC­MA ri­val to blue­bird, Bris­tol My­ers files for $100M IPO as the fron­trun­ners stum­ble in a race to the fin­ish line

6 years ago
Financing
R&D

What does a post-pan­dem­ic IPO fil­ing look like? Hong Kong biotech ap­pli­ca­tion of­fers clues

6 years ago
Financing

The bio­phar­ma fund­ing en­gine mo­tors on, as Chi­nese biotech rais­es near­ly $280M in mon­ster round

6 years ago
Financing
Startups

Chi­nese an­ti­body mak­er, famed for Ebo­la cock­tail, notch­es $160M as it fo­cus­es on can­cer, au­toim­mune drugs

6 years ago
Financing

Plough­ing through a crowd­ed PD-(L)1 mar­ket, BeiGene loads up on promis­ing lung can­cer da­ta

6 years ago
R&D
Pharma

Qim­ing's Chi­na-fo­cused $1.1B new fund brings glob­al haul to $5B with­in 1 week — but the dis­tri­b­u­tion won't be even

6 years ago
Financing

Mer­ck-part­nered an­ti­body mak­er read­ies $300M IPO as HKEX picks up pace

6 years ago
Financing

Lil­ly Asia Ven­tures co-leads $100M+ round for Chi­nese biotech and its late-stage lu­pus drug

6 years ago
Financing

Brii Bio gets all hands on deck for Covid-19 an­ti­body hunt, lever­ag­ing Chi­nese part­ner­s' work with re­cov­ered pa­tients

6 years ago
R&D
Coronavirus

BeiGene scram­bles to find new Abrax­ane sup­pli­er as Chi­nese in­spec­tors or­der halt on im­ports, cit­ing Bris­tol My­ers fail­ure

6 years ago
FDA+

In­no­Care IPO over­sub­scribed 300x as Hong Kong in­vestors turned to biotech amid runoff

6 years ago
Financing

A Japan­ese flu drug gets up­beat re­views in Chi­na for blunt­ing the im­pact of Covid-19 — and that is bol­ster­ing Gilead­'s case for remde­sivir

6 years ago
R&D
Coronavirus

Bay­er fires em­ploy­ee who was spot­ted break­ing quar­an­tine in Chi­na

6 years ago
Pharma
Coronavirus

The big C: The deal­mak­ers, dol­lars and dis­eases that have trans­formed the Chi­nese bio­phar­ma mar­ket

6 years ago
Financing
Deals

Is HKEX ready to re­turn to biotech busi­ness? In­no­Care tests wa­ters with hopes to fetch $257M in IPO

6 years ago
Financing

Chi­nese biotech bags $50M+ for I/O, au­toim­mune work, start­ing with ALK5 in­hibitor

6 years ago
Financing

FDA mon­i­tor­ing 20 drugs at risk of short­age due to coro­n­avirus

6 years ago
FDA+
Coronavirus

Har­vard joins coro­n­avirus fight with $115M and a high-pro­file Chi­nese part­ner

6 years ago
Deals
Coronavirus

Sanofi out­lines big API plans as coro­n­avirus out­break re­port­ed­ly threat­ens short­age of 150 drugs

6 years ago
Pharma

As coro­n­avirus out­break reach­es 'tip­ping point,' GSK lends ad­ju­vant tech to Chi­nese part­ner armed with pre­clin­i­cal vac­cine

6 years ago
Deals
Coronavirus

Eli Lil­ly vet Ker­ry Blan­chard takes the helm at one of Chi­na's top deal­mak­ers, steer­ing to­ward first ap­provals

6 years ago
People

RA joins glob­al syn­di­cate to back a $98M round for CAN­bridge

6 years ago
Financing

Chi­na ap­proves flu drug be­ing tout­ed as a po­ten­tial coro­n­avirus treat­ment amid a rush of clin­i­cal stud­ies

6 years ago
Coronavirus

Roche scores its first PD-L1 win in Chi­na, go­ing straight for SCLC niche

6 years ago
Pharma
First page Previous page 17181920212223 Next page Last page
A service from the Financial Times